Laura Solá
A5034127925- Advanced Biosensing Techniques and Applications
- Advanced biosensing and bioanalysis techniques
- Dialysis and Renal Disease Management
- Biosensors and Analytical Detection
- Chronic Kidney Disease and Diabetes
- Microfluidic and Capillary Electrophoresis Applications
- Health Systems, Economic Evaluations, Quality of Life
- Nanofabrication and Lithography Techniques
- Gene expression and cancer classification
- Monoclonal and Polyclonal Antibodies Research
- Blood Pressure and Hypertension Studies
- Organ Donation and Transplantation
- Microfluidic and Bio-sensing Technologies
- Renal and Vascular Pathologies
- Extracellular vesicles in disease
- Healthcare cost, quality, practices
- Polymer Surface Interaction Studies
- Click Chemistry and Applications
- Central Venous Catheters and Hemodialysis
- Innovative Microfluidic and Catalytic Techniques Innovation
- Healthcare Systems and Reforms
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Alzheimer's disease research and treatments
- COVID-19 and healthcare impacts
Barcelona IVI Clinic
2024-2025
Ministerio de Salud Pública
2015-2024
Centro Uruguayo de Imagenología Molecular
2014-2024
Artistic Realization Technologies
2024
RedCLARA
2024
National Research Council
2011-2023
Universidad Católica del Uruguay
2023
Istituto di Scienze e Tecnologie Chimiche "Giulio Natta"
2020-2022
Universidad de la República de Uruguay
2012-2022
Administracion de los Servicios de Salud del Estado
2019-2021
Chronic kidney disease (CKD) causes substantial global morbidity and increases cardiovascular all-cause mortality. Unlike other chronic diseases with established strategies for screening, there has been no consensus on whether health systems governments should prioritize early identification intervention CKD. Guidelines evaluating managing CKD are available but have not universally adopted in the absence of incentives or quality measures prioritizing care. The burden falls disproportionately...
Abstract Objective To determine the global capacity (availability, accessibility, quality, and affordability) to deliver kidney replacement therapy (dialysis transplantation) conservative management. Design International cross sectional survey. Setting Society of Nephrology (ISN) survey 182 countries from July September 2018. Participants Key stakeholders identified by ISN’s national regional leaders. Main outcome measures Markers core components Results Responses were received 160 (87.9%)...
Blood pressure (BP) and volume control are critical components of dialysis care have substantial impacts on patient symptoms, quality life, cardiovascular complications. Yet, developing consensus best practices for BP been challenging, given the absence objective measures extracellular status lack high-quality evidence many therapeutic interventions. In February 2019, Kidney Disease: Improving Global Outcomes (KDIGO) held a Controversies Conference titled Pressure Volume Management in...
The global nephrology community recognizes the need for a cohesive strategy to address growing problem of end-stage kidney disease (ESKD). In March 2018, International Society Nephrology hosted summit on integrated ESKD care, including 92 individuals from around globe with diverse expertise and professional backgrounds. attendees were 41 countries, 16 participants 11 low- lower-middle-income countries. purpose was develop strategic plan improve worldwide access by identifying prioritizing...
Home dialysis modalities (home hemodialysis [HD] and peritoneal [PD]) are associated with greater patient autonomy treatment satisfaction compared in-center modalities, yet the level of home-dialysis use worldwide is low. Reasons for limited utilization context-dependent, informed by local resources, costs, access to healthcare, health system policies, provider bias or preferences, cultural beliefs, individual lifestyle concerns, potential care-partner time, financial burdens. In May 2021,...
Chronic kidney disease (CKD) affects over 850 million people globally, and the need to prevent its development progression is urgent. During past decade, new perspectives have arisen related quality precision of care for CKD, owing tools interventions CKD diagnosis management. New biomarkers, imaging methods, artificial intelligence techniques, approaches organizing delivering healthcare may help clinicians recognize determine etiology, assess dominant mechanisms at given time points,...
Evidence-based cinical practice guidelines improve delivery of uniform care to patients with and at risk developing kidney disease, thereby reducing disease burden improving outcomes. These are not well-integrated into systems in most low- middle-income countries (LMICs). The KDIGO Controversies Conference on Implementation Strategies LMIC reviewed the current state knowledge order define a road map implementation guideline-based LMICs. An international group multidisciplinary experts...
Kidney failure is an important outcome for patients, clinicians, researchers, healthcare systems, payers, and regulators. However, no harmonized international consensus definitions of kidney key surrogates progression to exist specifically clinical trials. The International Society Nephrology convened multi-stakeholder meeting develop on this topic. A core group, experienced in design, conduct, adjudication trials, developed a database 64 randomized trials the 163 included relevant failure....
Optical biosensors based on plasmonic sensing schemes combine high sensitivity and selectivity with label-free detection. However, the use of bulky optical components is still hampering possibility obtaining miniaturized systems required for analysis in real settings. Here, a fully biosensor prototype detection demonstrated, which enables fast multiplex analytes high- low molecular weight (80 000 582 Da) as quality safety parameters milk: protein (lactoferrin) an antibiotic (streptomycin)....